
Overview
Nikalab is a company that produces dietary supplements for women, men, and children, focusing on health, well-being, and appearance. Their products include ingredients such as Omega-3 fatty acids, vitamins, and minerals, utilizing advanced capsule technologies to enhance absorption. They ensure high-quality production standards in France, complying with pharmaceutical regulations and using verified European suppliers.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Loss covered | |
| Foreign sales | 2.87% of revenue ($89,943) | |
| Revenue structure | Usługi |
Filing timeliness
4 of 5 financial statements were filed late (the longest delay 53 days for 2021).
- 202521/07/2026
- 202414/07/2025
- 202316/07/2024
- 202218/07/2023
- 202106/09/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
The sites are available in: Polish and English.
- nikalab.plZ dbałością o zdrowie, wygląd i samopoczucie | nikalabShopifyCloudflare
- ile.euInvest Line E SA | prosto do biznesuWordPress 6.9Apache
Job offers
The company lists 4 job openings on its own careers page: nikalab.pl/pages/praca.
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the sole member of the management board. In the case of a management board consisting of two or more persons, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board together with a commercial proxy, is authorized to make declarations on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Godlewska age 39 | 3,100 | $41,869.26 | 25.8333% |
Aleksandra Golecka-Kuźniak age 46 | 2,000 | $27,012.43 | 16.6667% |
| 2,450 | $33,090.22 | 20.4167% | |
Bogdan Marian Kaczmarek age 69 | 2,450 | $33,090.22 | 20.4167% |
Mirosław Godlewski | 1,000 | $13,506.22 | 8.3333% |
Nina Nicheska | 1,000 | $13,506.22 | 8.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-12-17.
46 1600 1462 1778 6879 1000 0001
24 1600 1462 1778 6879 1000 0009
32 1140 2004 0000 3812 1352 5946
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Panawit sp. z o.o. | $10,791,432.08 | panawit.pl | ||
| Wegafarm Plucińscy sp. k. | $6,100,664.89 | wegafarm.pl | ||
| Pharmacreator sp. z o.o. | $5,406,339.05 | pharmovit.pl | ||
| Bioticom sp. z o.o. | $2,659,090.32 | bioticom.pl | ||
| Proton Labs sp. z o.o. | $2,382,339.08 | protonlabs.pl | ||
| Akuna Polska sp. z o.o. | $2,025,454.04 | akuna.pl | ||
| Forest Pharma sp. z o.o. | $1,838,788.45 | forestpharma.pl | ||
| Amilek sp. z o.o. | $1,792,976.38 | amilek.pl | ||
| Pharma Nord sp. z o.o. | $1,701,654.59 | pharmanord.pl | ||
| Noblepharma sp. z o.o. | $1,695,021.71 | noblepharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-05-31 | Share capital increase (400,000.00 PLN → 600,000.00 PLN) | |
| 2021-07-29 | Address change (Ul. Środkowa 33, 05-080, Izabelin C → Ul. Franciszka Klimczaka 1, 02-797, Warszawa) | |
| 2021-04-15 | Share capital increase (200,000.00 PLN → 400,000.00 PLN) | |
| 2021-03-05 | Share capital increase (150,000.00 PLN → 200,000.00 PLN) | |
| 2020-11-30 | Entered in the register |
FAQ
Last updated: 2026-07-21